Baidu
map

Am J Geriatr Psychiatry:脑血管风险与老年精神病患者的重度抑郁有关

2015-12-30 徐媛 MedSci原创

本研究旨在研究老年患者的脑血管风险、执行能力和处理速度与精神病性抑郁症的急性治疗结果是否有关。 研究人员纳入了142名具有精神病特征的重度抑郁老年患者,年龄在60岁以上,并将患者随机分配至奥氮平+舍曲林组和奥氮平+安慰剂组,进行一项为期12周的随机对照试验(RCT)。研究中的独立变量是基线脑血管风险(Framingham卒中风险评分)、基线执行能力(Stroop干扰评分和Mattis痴呆评定量表

本研究旨在研究老年患者的脑血管风险、执行能力和处理速度与精神病性抑郁症的急性治疗结果是否有关。

研究人员纳入了142名具有精神病特征的重度抑郁老年患者,年龄在60岁以上,并将患者随机分配至奥氮平+舍曲林组和奥氮平+安慰剂组,进行一项为期12周的随机对照试验(RCT)。研究中的独立变量是基线脑血管风险(Framingham卒中风险评分)、基线执行能力(Stroop干扰评分和Mattis痴呆评定量表的起始/持续分量表)以及基线处理速度(Stroop的颜色和单词阅读部分)。结果变量是抑郁程度的变化,在研究过程中通过17项Hamilton抑郁量表总分进行评估。

随着时间的推移,在控制了相关协变量之后,若抑郁的严重程度得不到较好的改善,则会明显增加基线脑血管病的风险。执行能力和处理速度不能预测结果。

这项研究表明脑血管风险与老年精神病患者的重度抑郁有关,但与执行能力和处理速度不能预测结果。

原始出处

Bingham KS1, Whyte EM2, Meyers BS3, Mulsant BH4, Rothschild AJ5, Banerjee S6, Flint AJ7; STOP-PD Study Group.Relationship Between Cerebrovascular Risk, Cognition, and Treatment Outcome in Late-Life Psychotic Depression.Am J Geriatr Psychiatry. 2015 Dec;

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2082368, encodeId=0802208236842, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Sun Oct 23 05:02:00 CST 2016, time=2016-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021516, encodeId=e2c62021516a7, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Mar 14 09:02:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042446, encodeId=a45d204244687, content=<a href='/topic/show?id=d728e65519c' target=_blank style='color:#2F92EE;'>#精神病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76551, encryptionId=d728e65519c, topicName=精神病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Fri Jun 17 16:02:00 CST 2016, time=2016-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791968, encodeId=78e11e91968e3, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Sat Mar 19 02:02:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=52221, encodeId=805552221e3, content=以前没做碰见过这一类的研究,好棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151216/IMG567040728D7F67408.jpg, createdBy=c9011670983, createdName=小玉6951, createdTime=Tue Jan 05 19:41:00 CST 2016, time=2016-01-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2082368, encodeId=0802208236842, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Sun Oct 23 05:02:00 CST 2016, time=2016-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021516, encodeId=e2c62021516a7, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Mar 14 09:02:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042446, encodeId=a45d204244687, content=<a href='/topic/show?id=d728e65519c' target=_blank style='color:#2F92EE;'>#精神病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76551, encryptionId=d728e65519c, topicName=精神病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Fri Jun 17 16:02:00 CST 2016, time=2016-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791968, encodeId=78e11e91968e3, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Sat Mar 19 02:02:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=52221, encodeId=805552221e3, content=以前没做碰见过这一类的研究,好棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151216/IMG567040728D7F67408.jpg, createdBy=c9011670983, createdName=小玉6951, createdTime=Tue Jan 05 19:41:00 CST 2016, time=2016-01-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2082368, encodeId=0802208236842, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Sun Oct 23 05:02:00 CST 2016, time=2016-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021516, encodeId=e2c62021516a7, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Mar 14 09:02:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042446, encodeId=a45d204244687, content=<a href='/topic/show?id=d728e65519c' target=_blank style='color:#2F92EE;'>#精神病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76551, encryptionId=d728e65519c, topicName=精神病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Fri Jun 17 16:02:00 CST 2016, time=2016-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791968, encodeId=78e11e91968e3, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Sat Mar 19 02:02:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=52221, encodeId=805552221e3, content=以前没做碰见过这一类的研究,好棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151216/IMG567040728D7F67408.jpg, createdBy=c9011670983, createdName=小玉6951, createdTime=Tue Jan 05 19:41:00 CST 2016, time=2016-01-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2082368, encodeId=0802208236842, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Sun Oct 23 05:02:00 CST 2016, time=2016-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021516, encodeId=e2c62021516a7, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Mar 14 09:02:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042446, encodeId=a45d204244687, content=<a href='/topic/show?id=d728e65519c' target=_blank style='color:#2F92EE;'>#精神病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76551, encryptionId=d728e65519c, topicName=精神病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Fri Jun 17 16:02:00 CST 2016, time=2016-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791968, encodeId=78e11e91968e3, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Sat Mar 19 02:02:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=52221, encodeId=805552221e3, content=以前没做碰见过这一类的研究,好棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151216/IMG567040728D7F67408.jpg, createdBy=c9011670983, createdName=小玉6951, createdTime=Tue Jan 05 19:41:00 CST 2016, time=2016-01-05, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2082368, encodeId=0802208236842, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Sun Oct 23 05:02:00 CST 2016, time=2016-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021516, encodeId=e2c62021516a7, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Mar 14 09:02:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2042446, encodeId=a45d204244687, content=<a href='/topic/show?id=d728e65519c' target=_blank style='color:#2F92EE;'>#精神病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76551, encryptionId=d728e65519c, topicName=精神病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7c9348, createdName=neizongke, createdTime=Fri Jun 17 16:02:00 CST 2016, time=2016-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791968, encodeId=78e11e91968e3, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Sat Mar 19 02:02:00 CST 2016, time=2016-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=52221, encodeId=805552221e3, content=以前没做碰见过这一类的研究,好棒, beContent=null, objectType=article, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151216/IMG567040728D7F67408.jpg, createdBy=c9011670983, createdName=小玉6951, createdTime=Tue Jan 05 19:41:00 CST 2016, time=2016-01-05, status=1, ipAttribution=)]
    2016-01-05 小玉6951

    以前没做碰见过这一类的研究,好棒

    0

相关资讯

BMC Nephrol:亟需在伴抑郁的透析患者开展高质量随机对照研究

接受血液透析患者的抑郁患病率约为20%-40%。因苦于明显的方法学问题,鲜有关于抗抑郁药对透析患者的有效性临床研究。近期有学者在诊断为严重抑郁的透析患者中评估了开展随机对照试验的可行性。相关论文发表于《BMC肾脏病学》(BMC Nephrol)杂志。该项试验是一项2期筛选阶段的随机对照研究。最初筛选出贝克抑郁量表评分为16分及以上的患者,这些患者被精神病学家诊断为严重抑郁,并受邀参与试验。参与试验

BMJ Open:抗抑郁治疗时应警惕躁狂症的发生

本研究旨在探讨抗抑郁药治疗与日后躁狂症/双相情感障碍发生之间的关系。

Stroke:哪些卒中幸存者发生抑郁风险较高?

背景和目的:尽管卒中后抑郁较常见,抑郁发生是否存在种族差异尚不清楚。因此,研究者在多种族卒中队列研究中调查种族和抑郁的关系。方法:在社区居住的城市脑卒中/短暂性脑缺血发作的患者中进行的预防卒中再发的研究中,调查患者基线抑郁和功能状态的量表,人口学资料,共发病和社会经济状态。结果:包括556名受试者,平均年龄64岁。绝大多数是黑人(44%)和拉丁美洲人(42%)和女性(60%),招募的受试者最后一次

Am J Psychiatry:严重抑郁症的内侧额叶畸变

目的:已经证实异质人额叶是作为严重抑郁症功能失调网络的一个节点。内侧(社会情感)VS 侧部(认知)额叶对于抑郁症的主要发病机制目前还不清楚。作者使用形态测定,比较抑郁病人之间的额叶微观结构,用单变量和多变量进行统计。方法:对73例抑郁症病人和73例无精神疾病史的正常对照组进行多点以像素和区域为基础的形态学测定的MRI分析。首先通过wise-细分形态分析比较抑郁患者和对照组的额叶体积。第二种方法,通

JAMA:医生抑郁比例高

图片来源:网络医生工作繁重、压力偏大已是众所周知,医生的心理健康也因此越来越受到关注。美国一项最新研究发现,住院医生的抑郁症患病率的确高于平均水平。医生的心理健康不只影响他们的个人生活,还与医疗服务态度和品质有关,甚至会增加医疗差错的发生率。近年来,有关医生抑郁症患病率的研究数量不少,但可能由于研究样本数量、研究方法等方面的差异,研究结果并不一致。《美国医学会杂志》12月8日刊登一项最新研究,来自

Psychosom Med:抑郁会降低癌症患者生存期

先前有研究表明抑郁与癌症患者死亡率具有一定关系。研究者对新近诊断的鳞状细胞口咽癌患者进行前瞻性研究,从放射治疗开始直到患者死亡或最后一次临床随访。 所有患者均进行了放疗和偶尔的化疗。校正肿瘤分期、治疗、并发症、吸烟、饮酒、人口统计学等因素后,评估自我报道的抑郁与整体生存期和复发的关系。研究者对平均年龄56岁的130名患者中位数随访了5年,其中83%是男性。研究期间发生了18例死亡和15例复发。研究

Baidu
map
Baidu
map
Baidu
map